N/A N=265 Physician Radiation Exposure During Radial Access Cardiac Catheterization Using a RAD Board
Radiation Exposure to Operator
Primary: Operator Radiation Exposure — .65; .56 mSv
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=55 Radiation Exposure of ERCP Personnel at Different Standing Locations and Different Patient Positions.
Occupational Radiation Exposure
Primary: Effective Radiation Dose — 0.0307; 0.0192 mSv
N/A N=170 Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation
Cardiac Catheterization · Radiation Exposure
Primary: Radiation Dose to Primary Operator (RaySafe), Cardiac Catheterization — 18; 39 microsievert
N/A N=10 Dosimeter Location in Pain Physicians
RAD
Primary: Radiation Readings — 122.8; 158.8; 236.9 mREM
N/A N=1,000 ATTENUATE (rAdpad proTecTion drapE iN redUcing rAdiaTion Exposure) Trial
Radiation Exposure
Primary: Operator Exposure (OE)/Dose Area Product (DAP) (uSv[Micro-Sieverts]/mGy[Milligray]*cm2) of the Proximal Operator — 6.41; 3.51 10,000 x uSv / mGy*cm^2
N/A N=197 Radioprotective Light-weight Caps in the Interventional Cardiology Setting
Occupational Exposure to Radiation
Primary: Radiation Attenuation in Percentage (%) — 12; 91.5; 97.1 Percentage
N/A N=20 Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation
Node Positive Breast Cancer
Primary: Cardiac MRI Parameters — 0; 0; 0; 0 number of patients
N/A N=6,700 Adult and Paediatric Patient Radiation Doses From Multidetector Row Computed Tomography Scans: a National Survey
Cancer
Primary: Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Head CT Examinations. — 64; 28.7 mGy
N/A N=228 Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
Coronary Artery Disease · Chest Pain
Primary: Number of Excess Double-strand DNA Break Foci Per Cell in Peripheral Blood Samples Post-imaging — 0.183; 0.159 gamma-H2AX foci in blood lymphocytes — p=<0.05
N/A N=72 Breast Displacement and CT Radiation Dose
Computed Tomography · Radiation Dosage
Primary: Skin Entrance Radiation Dose During Computed Tomography (CT) — 1775; 1325; 625; 259 mrad
N/A N=20 Normal Tissue Oxygenation Following Radiotherapy
Radiation Toxicity
Primary: Tissue Oxygenation — 62.5 mmHg — p=0.5
N/A N=1,472 Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Primary: Number of Participants With Second Primary Malignancies (SPM) — 24 Participants
Phase 2 N=187 RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
Breast Cancer
Primary: Time-averaged Effect on Radiation Dermatitis Grade Measured With Common Terminology Criteria for Adverse Events (CTCAE, v 4.03) Following 3D Conformal Radiation Therapy…
Phase 2 N=19 Radioactive Iodide Therapy for Pediatric Graves' Disease
Graves' Disease
Primary: Dosimetry Studies
N/A N=543 Virtual Sun Safe Workplaces Ph II (SSW Works)
Skin Cancer · Occupational Exposure
Primary: Change From Baseline Employee Sun Protection Practices at 1 Year — 3.55; 3.30; 3.71; 3.46 score on a scale
N/A N=117 Heterotopic Ossification Prophylaxis
Acetabular Fracture · Heterotopic Ossification
Primary: Number of Participants With Severe HO Formation — 3; 9 Participants
N/A N=27 UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization
Breast Cancer
Primary: Number of Computed Tomography (CBCTs) a Participant Receives During Radiation Therapy Treatment as Quantified Via Counting the Number Used During the Setup Process. — 2…
N/A N=864,080 CT DOSE Collaboratory
Ionizing Radiation Exposure · Quality Improvement
Primary: Change in Mean Effective Dose (ED) — -0.13; -0.81; -0.14; -0.26 Millisieverts (mSv)
N/A N=12 Effect of High Doses of Radiation on Bone Structure and Metabolism
Malignant Bone Tumors
Primary: Change in Bone Mineral Density (Tb. BMD) — 4.5; -39.3; -8.7; -54.7 mg/cm^3
Phase 1 N=15 A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma
Lymphoma, Follicular
Primary: Area Under the Curve (AUC) at 0 to 120, 0 to 168, and 0 to Infinity Hours — 1.04; 1.18; 1.39 %ID.h/mL
N/A N=63 Reduced Radiation in Patients With Diffuse Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma
Primary: Number of Participants With Local Control — 61 Participants
N/A N=268 Work Should Not Hurt You: Reduction of Hazardous Exposures in Small Businesses Through a Community Health Worker Intervention
Community Health Aides · Industrial Hygiene · Volatile Organic Compounds
Primary: Change in Volatile Organic Chemical Concentrations From Pre- to Post-Intervention — 2738; 3875; 523; 225 ppb
N/A N=71 Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer
Breast Cancer
Primary: Rates of Good/Excellent Cosmesis as Measured by the Radiation Therapy Oncology Group (RTOG) Cosmetic Rating Scale - Rated by Physician — 45 Participants
N/A N=77 A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma
Hepatocellular Carcinoma
Primary: The Proportion of Patients for Whom the Intended Treatment Was Feasible — 70 Participants
Phase 3 N=44 Proton/Photon Rt - Benign Meningiomas(P92-13)
Benign Meningioma
Primary: Progression Free Survival — 91; 91; 86; 81 percentage of participants surviving — p=0.234
Phase 2 N=43 A Study of Patients Receiving High-Dose Rate Brachytherapy
Cervical Cancer · Endometrial Cancer · Esophageal Cancer
Primary: Number of Participants Who Had Adequate High-Quality Brachytherapy Implants Reported Per Strata (Four Body Sites) and Combined Overall — 27; 0; 0; 14 Participants
N/A N=23 Internal Radiation Therapy in Treating Patients With Prostate Cancer
Prostate Cancer
Primary: Number of Patients With an Acceptable Level of Severe Toxicity as Defined at < Grade 3 CTC Toxicity — 20 participants
N/A N=20 Late Effects of Proton Radiation Therapy in Patients With Low-Grade Glioma
Low Grade Gliomas
Primary: Number of Participants With Late Effects > 3 Months Post RT — 20 Participants
N/A N=74 Using Non-Fluoroscopic Imaging Devices to Decrease Radiation Exposure During Ablation of Supraventricular Tachycardia
Supraventricular Tachycardia
Primary: Total Fluoroscopy Time — 18.3; 7.5 minutes
N/A N=30 Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer
Head and Neck Cancer
Primary: Time Until the Maximum Oral Mucositis Measured From the Start of Radiation Treatment. — 34; 29 Days — p=0.9906